TickerTry: NVDA · AAPL · PLTR · NFLX
NASDAQ · Healthcare · Biotechnology

Rapport Therapeutics, Inc. Common Stock

RAPP

Rapport Therapeutics, Inc. CEO Abraham N. Ceesay · Market cap $1.1B.

$23.16
-0.43 · -1.82%
52w hi $52.9352w lo $22.06
Off 52w high 52.7%
81
STRONG
Current InsiderScore
Corp · 90d
11
11 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
10
3 strong · 7 notable
Analyst consensus
Strong Buy
Avg PT $65.56
Section 01

Recent Form 4 filings

15 filings on file
DateInsiderRoleActionSharesPriceValueScore
Oct 28James HealyBuy3,772$21.00+$79K57
Oct 28James HealyBuy6,933$21.00+$146K60
Oct 28James HealyBuy6,395$21.00+$134K63
Oct 28James HealyBuy952,380$21.00+$20.00M72
Oct 23Ramiro SanchezBuy3,600$27.35+$98K60
Oct 22John MaraganoreBuy1,172$26.92+$32K66
Oct 22Wendy B. YoungBuy3,789$26.39+$100K72
Oct 22John MaraganoreBuy8,239$26.38+$217K78
Oct 22Steven M PaulBuy35,714$27.28+$974K81
Oct 22Paul M SilvaBuy3,680$27.07+$100K75
Oct 21Troy A. IgnelziChief Financial OfficerBuy5,500$26.10+$144K69
Sep 12Reid M HuberBuy20,400$24.48+$499K59
Sep 12Steven M PaulBuy28,284$24.50+$693K62
Sep 12Steven M PaulBuy13,382$24.97+$334K56
Sep 11Wendy B. YoungBuy3,500$22.60+$79K46
Section 02

Recent STOCK Act disclosures

No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03

InsiderScore history

Rolling 12 months · peak score per month
75 · STRONG60 · NOTABLE40 · ROUTINE
DecJanFebMarAprMayJunJulAugSepOctNov
/to search